Latest Methylphenidate Stories
KP415 is Designed as an Abuse-Deterrent, Controlled Release Prodrug of Methylphenidate for the Treatment of ADHD CORALVILLE, Iowa, Dec.
TORONTO, Nov. 20, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), a pharmaceutical company, today announced that the U.S.
PRINCETON, N.J., Nov. 14, 2014 /PRNewswire/ -- Kremers Urban Pharmaceuticals Inc. (KU) has been informed by the U.S.
- Study successfully meets primary endpoint- Lack of sleep-related side effects supports flexible nighttime dosing platform to target control over symptoms during the morning routine-
TORONTO, Oct. 16, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), a pharmaceutical company, today announced it has completed a US$25 million offering of Class A Common Shares.
TORONTO, Oct. 6, 2014 /PRNewswire/ - Highland Therapeutics Inc.
TORONTO, Sept. 24, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), today announced the appointment of Dr. Floyd R.
The Firm is currently representing clients in Risperdal lawsuits that allege the medication caused men and boys to develop gynecomastia, or male breast growth. New
TAU researchers develop diagnostic tool for the most commonly misdiagnosed disorder.
LEXINGTON, Massachusetts, July 17, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced top-line results from two Phase 4 efficacy and safety studies
- a meat pie that is usually eaten at Christmas in Quebec